EX-99.1 2 ohi-20260204xex99d1.htm EX-99.1 Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 Hunt Valley, MD 21030 PRESS RELEASE - FOR IMMEDIATE RELEASE OMEGA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS AND RECENT DEVELOPMENTS Completed $334 Million in New Investments in Q4 2025 Issued $223 Million in Equity in Q4 2025 Repaid $1.27 Billion of Aggregate Debt in Q4 2025 Providing 2026 Adjusted FFO Guidance HUNT VALLEY, MARYLAND - February 4, 2026 - Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter and year ended December 31, 2025. FOURTH QUARTER 2025 AND RECENT HIGHLIGHTS Net income for the quarter of $172 million, or $0.55 per diluted share, compared to $116 million, or $0.41 per diluted share, for Q4 2024. Adjusted Funds From Operations (“Adjusted FFO” or “AFFO”) for the quarter of $250 million, or $0.80 per diluted share, on 313 million weighted-average common shares outstanding, compared to $214 million, or $0.74 per diluted share, on 287 million weighted-average common shares outstanding, for Q4 2024. Funds Available for Distribution (“FAD”) for the quarter of $2…
Open exhibit ↗Current Report · Items 2.02, 9.01 · 8-K
Omega Healthcare Investors Inc.
OHINYSEEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 Regulation FD Disclosure On February 4, 2026, Omega Healthcare Investors, Inc. (“Omega”) issued a press release regarding its financial results for the quarter and year ended December 31, 2025. Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.…
Recent company filings
- Regulation FD DisclosureOct 5, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 1, 2026
- SCHEDULE 13G - filed by COHEN & STEERS, INC. regarding OMEGA HEALTHCARE INVESTORS INCAug 14, 2026
- 10-Q filingJul 30, 2026
- Results of Operations and Financial ConditionJul 29, 2026
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02 Regulation FD Disclosure
On February 4, 2026, Omega Healthcare Investors, Inc. (“Omega”) issued a press release regarding its financial results for the quarter and year ended December 31, 2025. Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.
The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.